Varnimcabtagene autoleucel for adults with relapsed or refractory B-cell precursor acute lymphoblastic leukaemia in Spain (CART19-BE-02): a multicentre, single-arm, phase 2 trial.

Ortiz-Maldonado V, Martínez-Cibrian N, Alserawan L, Español-Rego M, Navarro-Velázquez S, Albiol N, Oliver-Caldés A, Triguero A, Herrero-García M, Gutiérrez-Herrero S, Benítez-Ribas D, Paciello ML, Torrent A, Delgado-Serrano J, Sánchez-Castañón M, Calderón H, Mata JJ, Sánchez-Salinas A, Sáez-Peñataro J, Sans-Pola C, Calvo-Orteu M, López-Corral L, Kwon M, Rifón J, Charry P, Alonso-Fernández RA, Huguet M, Blázquez-Goñi C, Sánchez-Pina JM, Sánchez R, Rosa-Rosa JM, Martínez-López J, Blanquer M, Ribera JM, Urbano-Ispizua Á, Bachiller M, Palau L, Olesti E, Calvo G, Martín-Martín L, Orfao A, González-Navarro EA, Domenech G, Varea S, Juan M, Delgado J, Esteve J

Open source

DOI: 10.1016/s2352-3026(25)00328-x
Published: 2026 Mar
Container: The Lancet. Haematology
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/s2352-3026-25-00328-x,
  title = {Varnimcabtagene autoleucel for adults with relapsed or refractory B-cell precursor acute lymphoblastic leukaemia in Spain (CART19-BE-02): a multicentre, single-arm, phase 2 trial.},
  author = {Ortiz-Maldonado V and Martínez-Cibrian N and Alserawan L and Español-Rego M and Navarro-Velázquez S and Albiol N and Oliver-Caldés A and Triguero A and Herrero-García M and Gutiérrez-Herrero S and Benítez-Ribas D and Paciello ML and Torrent A and Delgado-Serrano J and Sánchez-Castañón M and Calderón H and Mata JJ and Sánchez-Salinas A and Sáez-Peñataro J and Sans-Pola C and Calvo-Orteu M and López-Corral L and Kwon M and Rifón J and Charry P and Alonso-Fernández RA and Huguet M and Blázquez-Goñi C and Sánchez-Pina JM and Sánchez R and Rosa-Rosa JM and Martínez-López J and Blanquer M and Ribera JM and Urbano-Ispizua Á and Bachiller M and Palau L and Olesti E and Calvo G and Martín-Martín L and Orfao A and González-Navarro EA and Domenech G and Varea S and Juan M and Delgado J and Esteve J},
  year = {2026},
  journal = {The Lancet. Haematology},
  doi = {10.1016/s2352-3026(25)00328-x},
  url = {https://doi.org/10.1016/s2352-3026(25)00328-x}
}

RIS

TY  - JOUR
TI  - Varnimcabtagene autoleucel for adults with relapsed or refractory B-cell precursor acute lymphoblastic leukaemia in Spain (CART19-BE-02): a multicentre, single-arm, phase 2 trial.
AU  - Ortiz-Maldonado V
AU  - Martínez-Cibrian N
AU  - Alserawan L
AU  - Español-Rego M
AU  - Navarro-Velázquez S
AU  - Albiol N
AU  - Oliver-Caldés A
AU  - Triguero A
AU  - Herrero-García M
AU  - Gutiérrez-Herrero S
AU  - Benítez-Ribas D
AU  - Paciello ML
AU  - Torrent A
AU  - Delgado-Serrano J
AU  - Sánchez-Castañón M
AU  - Calderón H
AU  - Mata JJ
AU  - Sánchez-Salinas A
AU  - Sáez-Peñataro J
AU  - Sans-Pola C
AU  - Calvo-Orteu M
AU  - López-Corral L
AU  - Kwon M
AU  - Rifón J
AU  - Charry P
AU  - Alonso-Fernández RA
AU  - Huguet M
AU  - Blázquez-Goñi C
AU  - Sánchez-Pina JM
AU  - Sánchez R
AU  - Rosa-Rosa JM
AU  - Martínez-López J
AU  - Blanquer M
AU  - Ribera JM
AU  - Urbano-Ispizua Á
AU  - Bachiller M
AU  - Palau L
AU  - Olesti E
AU  - Calvo G
AU  - Martín-Martín L
AU  - Orfao A
AU  - González-Navarro EA
AU  - Domenech G
AU  - Varea S
AU  - Juan M
AU  - Delgado J
AU  - Esteve J
PY  - 2026
JO  - The Lancet. Haematology
DO  - 10.1016/s2352-3026(25)00328-x
UR  - https://doi.org/10.1016/s2352-3026(25)00328-x
ER  -

APA

V, O., N, M., L, A., M, E., S, N., N, A., A, O., A, T., M, H., S, G., D, B., ML, P., A, T., J, D., M, S., H, C., JJ, M., A, S., J, S., C, S., M, C., L, L., M, K., J, R., P, C., RA, A., M, H., C, B., JM, S., R, S., JM, R., J, M., M, B., JM, R., Á, U., M, B., L, P., E, O., G, C., L, M., A, O., EA, G., G, D., S, V., M, J., J, D., & J, E. (2026). Varnimcabtagene autoleucel for adults with relapsed or refractory B-cell precursor acute lymphoblastic leukaemia in Spain (CART19-BE-02): a multicentre, single-arm, phase 2 trial.. The Lancet. Haematology. https://doi.org/10.1016/s2352-3026(25)00328-x

Source records

pubmed · retrieved 2026-09-26T15:24:12.757Z